Science Explorer Back to mapMap
Discussion
Research facility · DeLand · United States

Avail Clinical Research

availclinical.comROR OpenAlex
Research works
8
▼ 100% vs 2018-21
Citations
58
7.6 per fractional work
Top-10% rate
5.9%
all institutions 10.0%
Open access
32%
world 40%
International
13%
world 18%
Avail Clinical Research

Not ranked overall: Avail Clinical Research is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Avail Clinical Research work in?

In all years, 50% of research at Avail Clinical Research is in Social Sciences, 30% in Health Sciences. Its largest fields are Medicine (22%), Economics, Econometrics and Finance (20%), Social Sciences (17%). It does 1.5× the world's share of Social Sciences.

Social Sciences: 4 fractional works · 50.1% of its workEconomics, Econometrics and Finance: 2 fractional works · 19.6% of its workEconomics and Econometrics: 2 fractional works · 19.6% of its workSocial Sciences: 1 fractional works · 17.4% of its workEducation: 1 fractional works · 13.1% of its workDemography: 0 fractional works · 4.3% of its workArts and Humanities: 1 fractional works · 13.1% of its workPhilosophy: 1 fractional works · 8.8% of its workHistory and Philosophy of Science: 0 fractional works · 4.3% of its workHealth Sciences: 2 fractional works · 30.4% of its workMedicine: 2 fractional works · 21.6% of its workHepatology: 1 fractional works · 7.1% of its workEpidemiology: 0 fractional works · 4.2% of its workInfectious Diseases: 0 fractional works · 4.1% of its workHematology: 0 fractional works · 2.2% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.4% of its workRheumatology: 0 fractional works · 1.0% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.5% of its workOncology: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 8.8% of its workGeneral Health Professions: 1 fractional works · 8.8% of its workPhysical Sciences: 1 fractional works · 11.8% of its workEnvironmental Science: 1 fractional works · 9.6% of its workEcology: 0 fractional works · 4.3% of its workNature and Landscape Conservation: 0 fractional works · 4.3% of its workGlobal and Planetary Change: 0 fractional works · 0.9% of its workChemistry: 0 fractional works · 2.2% of its workOrganic Chemistry: 0 fractional works · 2.2% of its workLife Sciences: 1 fractional works · 7.7% of its workAgricultural and Biological Sciences: 0 fractional works · 5.2% of its workPlant Science: 0 fractional works · 4.3% of its workInsect Science: 0 fractional works · 0.9% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 1.2% of its workGenetics: 0 fractional works · 0.9% of its workMolecular Biology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.8% of its workImmunology and Microbiology: 0 fractional works · 0.5% of its workImmunology: 0 fractional works · 0.5% of its workALL ITS WORKAvail ClinicalResearch8fractional works, all years
Life Sciences8%Physical Sciences12%Health Sciences30%Social Sciences50%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Economics, Econometrics and Finance219.6%
    2. Social Sciences117.4%
    3. Arts and Humanities113.1%
    1. Medicine221.6%
    2. Health Professions18.8%
    1. Environmental Science19.6%
    2. Chemistry02.2%
    1. Agricultural and Biological Sciences05.2%
    2. Biochemistry, Genetics and Molecular Biology01.2%
    3. Pharmacology, Toxicology and Pharmaceutics00.8%
    4. Immunology and Microbiology00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Avail Clinical Research?

Ranked on the quality score, Daniel Gruener lead among researchers whose main affiliation is Avail Clinical Research.

  1. 1 Daniel Gruener United States · #2,870,966 worldwide 567 citations · 24 works
All ranked researchers at Avail Clinical Research

What are the most cited papers from Avail Clinical Research?

The most cited paper from Avail Clinical Research is "A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C" (Eric Lawitz, Daniel Gruener, John M. Hill et al., 2012), with 158 citations. Next come "GS‐9857 in patients with chronic hepatitis C virus genotype 1–4 infection: a randomized, double‐blind, dose‐ranging phase 1 study" (65) and "Safety, Pharmacokinetics and Pharmacodynamics of the Oral Toll-Like Receptor 7 Agonist GS-9620 in Treatment-Naive Patients with Chronic Hepatitis C" (31).

Most cited papers
#PaperReleasedCitations
1 A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C Eric Lawitz, Daniel Gruener, John M. Hill et al. · Journal of Hepatology 5 Feb 2012 158
2 GS‐9857 in patients with chronic hepatitis C virus genotype 1–4 infection: a randomized, double‐blind, dose‐ranging phase 1 study Maribel Rodriguez‐Torres, S. Glass, John M. Hill et al. · Journal of Viral Hepatitis Open access 9 Mar 2016 65
3 Safety, Pharmacokinetics and Pharmacodynamics of the Oral Toll-Like Receptor 7 Agonist GS-9620 in Treatment-Naive Patients with Chronic Hepatitis C Eric Lawitz, Daniel Gruener, Thomas C Marbury et al. · Antiviral Therapy 8 Aug 2014 31
4 High levels of functional divergence in toxicity towards prey among the venoms of individual pigmy rattlesnakes Sarah A. Smiley-Walters, Terence M. Farrell, H. Lisle Gibbs · Biology Letters Open access 6 Feb 2019 25
5 A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4 Bradley D. Vince, John M. Hill, Eric Lawitz et al. · Journal of Hepatology Open access 14 Jan 2014 24
All 19 most cited papers, with filters and sorting

Which research topics does Avail Clinical Research publish most on?

By volume in 2022-now: Diabetes Management and Research, HIV, Drug Use, Sexual Risk and Hyperglycemia and glycemic control in critically ill and hospitalized patients.

Diabetes Management and …0Diabetes Management and Research: 0 fractional worksHIV, Drug Use, Sexual Risk0HIV, Drug Use, Sexual Risk: 0 fractional worksHyperglycemia and glycem…0Hyperglycemia and glycemic control in critically ill and hospitalized patients: 0 fractional works
Endocrinology, Diabetes and MetabolismEpidemiology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  2. 2 HIV, Drug Use, Sexual Risk Epidemiology 0 works
  3. 3 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.6%not open68.4%

World: 40% of research is openly available.

with international co-authors12.8%domestic only87.2%

World: 18% is written across borders.

How has Avail Clinical Research's research output changed?

Output in 2022-2025 was 100% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Avail Clinical Research as a percentage of every work published that year, 0.0000016% in 2016.

0.00020%0.00040%Avail Clinical Research0.000012% in 20191980199020002010

Fractional works of Avail Clinical Research over all fractional works that year. How the balance of science has shifted.

Other research institutions in DeLand

All research institutions in DeLand

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Avail Clinical Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.